期刊档案 · Medicine-Immunology and Allergy
Human Antibodies
ISSN 1093-2607 · eISSN 1875-869X · SAGE Publications (formerly IOS Press)
Human Antibodies 订阅期刊,APC 约 4,150 美元,2025 年发文 11 篇,Scopus 收录。
研究范围
研究范围与定位
Human Antibodies 由 SAGE Publications (formerly IOS Press) 出版。按 OpenAlex 近年发文统计,该刊主要发表 Monoclonal and Polyclonal Antibodies Research、T-cell and B-cell Immunology、Protein purification and stability 等主题的论文,这 3 个主题约占 56.4%,主导子领域为 Immunology。(根据 OpenAlex 主题统计与中科院分区数据生成)
该刊近年发文主要集中在:Monoclonal and Polyclonal Antibodies Research(36.5%)、T-cell and B-cell Immunology(12.9%)、Protein purification and stability(7%)、Immunotherapy and Immune Responses(4.9%)、Systemic Lupus Erythematosus Research(4.6%)、Cancer Immunotherapy and Biomarkers(2.6%)、SARS-CoV-2 and COVID-19 Research(2.5%)、Viral Infectious Diseases and Gene Expression in Insects(2.2%);所属学科:Medicine、Immunology and Microbiology、Biochemistry, Genetics and Molecular Biology;来源标注的研究方向:Medicine-Immunology and Allergy。(领域画像由 OpenAlex 发文统计生成,占比为近似值,非期刊官方描述)
由 OpenAlex 主题分布与研究方向自动生成的领域画像,非期刊官方表述。
研究方向(LetPub):Medicine-Immunology and Allergy
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Monoclonal and Polyclonal Antibodies ResearchMedicine36.5%
- T-cell and B-cell ImmunologyImmunology and Microbiology12.9%
- Protein purification and stabilityBiochemistry, Genetics and Molecular Biology7%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.9%
- Systemic Lupus Erythematosus ResearchMedicine4.6%
- Cancer Immunotherapy and BiomarkersMedicine2.6%
- SARS-CoV-2 and COVID-19 ResearchMedicine2.5%
- Viral Infectious Diseases and Gene Expression in InsectsBiochemistry, Genetics and Molecular Biology2.2%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》( 2026年3月发布)未收录
该期刊未被此版本分区表收录。
期刊分区表( 2023年12月旧的升级版)未收录
该期刊未被此版本分区表收录。
CiteScore 分区(Scopus,2026 年 6 月版)
| 学科 | 分区 | 排名 | 百分位 |
|---|---|---|---|
| Immunology and Allergy | Q3 | 169/234 | 27% |
| Immunology | Q4 | 185/243 | 24% |
Scopus 按 CiteScore 在每个学科内为期刊排名,百分位 75 及以上为 Q1,每 25 为一档;与中科院分区是不同体系。LetPub
数据库收录
ScopusLetPub
国际期刊预警名单:各版本均未列入LetPub
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- CiteScore 2026-06
- 2.4LetPub ·
- SJR 2026-06
- 0.36LetPub ·
- SNIP 2026-06
- 0.36LetPub ·
- h-index
- 36OpenAlex ·
- i10-index
- 203OpenAlex ·
- 两年平均被引
- 3.21OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 732 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 1 | 0 | 199 |
| 2025 | 11 | 2 | 313 |
| 2024 | 27 | 4 | 344 |
| 2023 | 13 | 2 | 380 |
| 2022 | 10 | 4 | 389 |
| 2021 | 26 | 2 | 349 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 评审方式
- 单盲同行评审出版商官网
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
订阅期刊,文章需订阅或购买阅读,通常不收取版面费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / GBP 3,043 | — | — | |
| 出版商官网 | 有,金额未公布 | — | — |
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点6 项,摘自作者指南
- 摘要
- ≤ 200 词
- 关键词
- ≥ 4 个
- 参考文献格式
- Harvard 格式
- 首次投稿格式
- 允许不按期刊格式排版(free format)
- 推荐审稿人
- 可选
- 投稿信(Cover letter)
- 必须提供
接收的文章类型8 种
- case reportOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- editorialOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- letterOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- letter to the editorOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- original research articleOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- research articleOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- research paperOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- reviewOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
官网政策摘录作者资格、数据可用性、出版伦理、开放获取、同行评审、查重、预印本、试验注册 / 报告规范
- 作者资格 Author contributions
该期刊采用CRediT(贡献者角色分类法)描述每位作者的个人贡献,投稿时需列出每位作者的贡献,并在致谢部分之后加入“作者贡献”标题。 模型中文摘要
As part of our commitment to ensuring an ethical, transparent and fair peer review and publication process, this journal has adopted CRediT (Contributor Roles Taxonomy). CRediT is a high-level taxonomy, including 14 roles, which is used to describe each author’s individual contributions to the work. You will be asked to list the contribution of each author as part of the submission process. Please…
原文 ↗出版商官网 ·- 数据可用性 Data availability
该期刊鼓励作者在符合伦理和法律要求的前提下,将研究数据存入相关公共数据仓库、提供数据可用性声明并在研究中引用该数据;若无法共享数据,需在声明中说明原因。 模型中文摘要
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
原文 ↗出版商官网 ·- 出版伦理 Ethical considerations
涉及人类参与者、人类数据或人体组织的研究,必须声明相关伦理委员会或机构审查委员会批准或豁免审批,并提供审查委员会全称、所属机构及批准号;若无需伦理批准,也须明确说明。 模型中文摘要
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
原文 ↗出版商官网 ·- 开放获取 Publishing fees and open access
向该期刊投稿或发表无需支付任何费用,在线版彩色图片免费,印刷版彩色图片费用在制作阶段确定;可通过Sage Choice计划或开放获取协议付费选择开放获取,开放获取费用不包含版面费或彩图费且单独收取。 模型中文摘要
There are no fees payable to submit or publish in this journal. Figures submitted in color will be published in color in the online version of the journal at no cost. If you wish to have color figures in the printed version, fees will be determined and applied at production stage. Optional open access publishing is available for a fee via the Sage Choice program, and Open Access agreements, where …
原文 ↗出版商官网 ·- 同行评审 Peer review policy
该期刊实行单盲同行评审,审稿人与编辑互动,不公布审稿信息;稿件先经初步评估,不符合要求将被退回修改,超出范围或不合适的稿件可能未经同行评审即被编辑拒稿。 模型中文摘要
The following summary describes the peer review process for this journal: Identity transparency: Single anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
原文 ↗出版商官网 ·- 查重 Plagiarism
期刊和Sage高度重视版权侵权、抄袭及其他违反出版最佳实践的行为,请阅读Sage完整的抄袭政策及其可能采取的措施。 模型中文摘要
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
原文 ↗出版商官网 ·- 预印本 Preprints
该期刊接受已在预印本服务器发布的稿件,投稿时需在指定字段填写预印本DOI,并建议在投稿时告知编辑部;同行评审期间不应在预印本服务器发布更新版本。 模型中文摘要
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical trial registration
该期刊遵循ICMJE要求,临床试验须在首位受试者入组时或之前在WHO认可的公共试验注册机构注册;符合AllTrials运动的补注册试验若能说明延迟注册理由可被考虑,且试验注册机构名称、网址及注册号必须列于摘要末尾。 模型中文摘要
The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be …
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- SAGE Publications (formerly IOS Press)
- ISSN
- 1093-2607
- 电子版 ISSN
- 1875-869X
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗出版商官网
- 作者指南 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Human Antibodies 的常见问题
Human Antibodies 的投稿格式要求是什么?
据期刊作者指南:摘要:≤ 200 词;关键词:≥ 4 个;参考文献格式:Harvard 格式;首次投稿格式:允许不按期刊格式排版(free format);推荐审稿人:可选;投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
Human Antibodies 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,Human Antibodies 被 Scopus 收录。
Human Antibodies 是开放获取期刊吗?版面费多少?
Human Antibodies 为订阅期刊。APC 约 4,150 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。